The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 03, 2015
Filed:
Dec. 18, 2008
Applicants:
Lyne Gagnon, Laval, CA;
Lilianne Geerts, St-Lazare, CA;
Christopher Penney, Pierrefonds, CA;
Inventors:
Assignee:
Prometic Biosciences Inc., Mont-Royal, Quebec, CA;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/7068 (2006.01); A61K 31/517 (2006.01); A61K 31/23 (2006.01); A61K 31/20 (2006.01); A61P 35/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/23 (2013.01); A61K 31/20 (2013.01); A61K 31/517 (2013.01); A61K 31/7068 (2013.01);
Abstract
The present invention relates to the use of medium-chain length fatty acids of formula I, triglycerides of formula 2 (wherein n=6-10), salts thereof, or mixtures thereof, in combination with gemcitabine and optionally erlotinib in the treatment of pancreatic cancer in human patients. Exemplary medium-chain length fatty acid/triglyceride compounds include capric acid, sodium caprate, tricaprin, lauric acid, sodium laurate, and trilaurin.
Gagnon, Lyne. (2015). Medium-chain length fatty acids, salts and triglycerides in combination with gemcitabine for treatment of pancreatic cancer (U.S. Patent No. 8946190). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/8946190
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile